Case Study
Cntrl+ Commercial Build
Built the commercial function from zero for a prescription, FDA-cleared femtech device, including GTM strategy, telehealth partnership and omnichannel acquisition. Paying customers in all 50 states within 90 days of launch, supporting a $2M seed round.
$1B ARR
Morgan led U.S. partnerships and business development at Fullscript during a period of hyper-growth. She managed integrations across health systems, MSOs, and pharmacies while the platform scaled from baseline toward institutional leadership.
30+
EHR Integrations
5×
Revenue Growth
US
Market Expansion
Global Expansion & Presence
Commercial experience bringing pharmacogenomics and clinical diagnostics into health systems, national registries, and specialty networks across 30+ international markets.
United Kingdom
Germany
France
Italy
Spain
Switzerland
Netherlands
Belgium
Norway
Sweden
Denmark
Finland
Australia
Japan
South Korea
Singapore
Hong Kong
Canada
Brazil
Mexico
Saudi Arabia
United Arab Emirates
Israel
South Africa
India
Qatar
Kuwait
Ireland
[DUE DILIGENCE]
Specialized commercial due diligence for private equity and venture capital investors evaluating health tech, diagnostics, and medical device assets. We map the intricate go-to-market pathways across payers, PBMs, and health systems, providing an objective assessment of how money and adoption incentives flow before capital is deployed.